Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for VYCO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 0.8132M
March 31, 2026 0.8541M
December 31, 2025 0.8304M
September 30, 2025 0.9412M
June 30, 2025 0.8789M
March 31, 2025 0.9408M
December 31, 2024 0.9981M
September 30, 2024 1.075M
June 30, 2024 0.997M
March 31, 2024 0.9688M
December 31, 2023 0.9923M
September 30, 2023 1.054M
June 30, 2023 0.9054M
March 31, 2023 0.8352M
December 31, 2022 0.8602M
September 30, 2022 0.9498M
June 30, 2022 0.9102M
March 31, 2022 0.933M
December 31, 2021 0.9354M
September 30, 2021 1.040M
June 30, 2021 1.064M
March 31, 2021 0.9679M
December 31, 2020 0.9865M
September 30, 2020 1.029M
June 30, 2020 1.011M
Date Value
March 31, 2020 1.133M
December 31, 2019 1.092M
September 30, 2019 1.086M
June 30, 2019 1.129M
March 31, 2019 1.191M
December 31, 2018 1.044M
September 30, 2018 1.410M
June 30, 2018 1.270M
March 31, 2018 1.360M
December 31, 2017 1.450M
September 30, 2017 1.740M
June 30, 2017 1.823M
March 31, 2017 2.080M
December 31, 2016 1.485M
September 30, 2016 1.543M
June 30, 2016 1.682M
March 31, 2016 1.764M
December 31, 2015 2.023M
September 30, 2015 2.384M
June 30, 2015 2.755M
March 31, 2015 3.237M
December 31, 2014 3.814M
September 30, 2014 4.456M
June 30, 2014 4.793M
March 31, 2014 4.861M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 109.22B
AngioDynamics, Inc. 267.16M
Alphatec Holdings, Inc. 791.03M
AtriCure, Inc. 676.64M
Baxter International, Inc. 19.79B

Total Assets (Quarterly) Related Metrics